This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/LIV.14308 This article is protected by copyright. All rights reserved PROF. ENAS KAMAL (Orcid ID : 0000-0003-4872-7957) DR. MOSTAFA YAKOOT (Orcid ID : 0000-0002-6783-8268) DR. DINA ATTIA (Orcid ID : 0000-0001-8374-2533) Article type : Original Articles Editor : Alessio Aghemo Effects of Sofosbuvir/ledipasvir therapy on chronic hepatitis C virus genotype 4, infected children of 3 to 6 years of age Enas M. Kamal 1 , Mortada El-Shabrawi 2 , Hisham El-Khayat 3 , Mostafa Yakoot 4 , Yehia Sameh 5 , Yasser Fouad 1 , Dina Attia 5 1Department of Gastroenterology, Hepatology and Endemic Medicine, Minia University Hospitals, 2Pediatric and Pediatrics Hepatology Department, Faculty of Medicine, Cairo University. 3Department of Gastroenterology, Hepatology and Endemic Medicine, Theodore Bilharz Research Institute, 4Green Clinic Research Centre, Alexandria, 5Department of Hepatology, Gastroenterology and Endemic Medicine, Faculty of Medicine, Beni-Suef University. Type: original manuscript Short title: sofosbuvir/ledipasvir in 3-6 years children Word count (abstract): 250 Word count Manuscript: 2473 excluding abstract, references, tables. Tables: 2 References: 22 Correspondence to: Accepted Article